Skydew Pharmaceutical Private Limited
About Skydew Pharmaceutical Private Limited
Data last updated:
Skydew Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 July 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U47721UP2023PTC186469.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Krishna Pratap Singh and Ravi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.52 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.03 Lakh (net margin 0.7%) and EBITDA of ₹1.67 Lakh (EBITDA margin 1.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS – 118 T P Nagar, Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Skydew Pharmaceutical Private Limited
The main business activity of Skydew Pharmaceutical is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Skydew Pharmaceutical Private Limited FY 2025 filings available
Skydew Pharmaceutical Private Limited reported revenue of ₹1.52 Cr (up 283% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Skydew Pharmaceutical Private Limited
Revenue rose 283% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Skydew Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹1.67 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹1.03 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Skydew Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.1% | •••• |
| Net Profit Margin | 0.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Skydew Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Skydew Pharmaceutical Private Limited
Skydew Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emergee Pharma Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Uttar Pradesh, India |
| Leelabco Remedies Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Lalith Pharma-Marketing Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Banagalore, Karnataka, India |
| Shree Vishwamitra Ayurved Pharmaceuticals Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Afd Laboratories Private Limited | ₹1.53 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Skydew Pharmaceutical Private Limited this company | ₹1.52 Cr (FY 2025) | •••• | •••• | 283.0% | •••• | Lucknow, Uttar Pradesh, India |
| Cure Quick Pharma Private Limited | ₹1.52 Cr (FY 2021) | •••• | •••• | -65.0% | •••• | New Delhi, Delhi, India |
| Wytech Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Chandigarh, India |
| Sahana Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Nagercoil, Tamil Nadu, India |
| Aaryan Biocare Products Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Pune, Maharashtra, India |
| Bharat Remedies Pvt Ltd | ₹1.52 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Skydew Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Skydew Pharmaceutical Private Limited
Skydew Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Pratap Singh | Director | 28 Jul 2023 | 3 Years 2 Months | Current |
| Ravi Kumar | Director | 28 Jul 2023 | 3 Years 2 Months | Current |
Charges & Borrowings of Skydew Pharmaceutical Private Limited
Skydew Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Skydew Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Skydew Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Skydew Pharmaceutical Private Limited
Skydew Pharmaceutical Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Krishna Pratap Singh was appointed as Director on 28 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Skydew Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Skydew Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Skydew Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Skydew Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Skydew Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skydew Pharmaceutical Private Limited
Skydew Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 July 2023 (3+ years old) and is registered under CIN U47721UP2023PTC186469.
Skydew Pharmaceutical reported revenue of ₹1.52 Cr for FY 2025 (up 283% YoY).
Skydew Pharmaceutical has 2 current directors:
- Krishna Pratap Singh - Director
- Ravi Kumar - Director
Skydew Pharmaceutical reported a net profit of ₹1.03 Lakh (net margin 0.7%) and EBITDA of ₹1.67 Lakh (EBITDA margin 1.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Skydew Pharmaceutical is U47721UP2023PTC186469. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skydew Pharmaceutical was incorporated on 28 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Skydew Pharmaceutical by revenue are Emergee Pharma Private Limited, Leelabco Remedies Private Limited, Lalith Pharma-Marketing Private Limited, Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Afd Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Krishna Pratap Singh was appointed as Director on 28 Jul 2023. Neeraj Pandey was appointed as Individual Subscriber on 28 Jul 2023. Ravi Kumar was appointed as Director on 28 Jul 2023. Skydew Pharmaceutical has 4 board changes on record in total.
The registered office of Skydew Pharmaceutical is at S – 118 T P Nagar, Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
Skydew Pharmaceutical has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.
Skydew Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.